Aberrant methylation of CDH13 can be a diagnostic biomarker for lung adenocarcinoma

Background: Aberrant methylation of CpG islands in tumor cells in promoter regions is a critical event in non-small cell lung carcinoma (NSCLC) tumorigenesis and can be a potential diagnostic biomarker for NSCLC patients. The present study systemically and quantitatively reviewed the diagnostic abil...

Descripción completa

Detalles Bibliográficos
Autores principales: Pu, Weilin, Geng, Xin, Chen, Sidi, Tan, Lixing, Tan, Yulong, Wang, An, Lu, Zhouyi, Guo, Shicheng, Chen, Xiaofeng, Wang, Jiucun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5166538/
https://www.ncbi.nlm.nih.gov/pubmed/27994665
http://dx.doi.org/10.7150/jca.15758

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5166538/
https://www.ncbi.nlm.nih.gov/pubmed/27994665
http://dx.doi.org/10.7150/jca.15758

Ejemplares similares